WHO gives emergency approval to China’s Sinopharm coronavirus vaccine

> Few older adults (over 60 years) were enrolled in clinical trials, so efficacy could not be estimated in this age group. Nevertheless, WHO is not recommending an upper age limit for the vaccine because preliminary data and supportive immunogenicity data suggest the vaccine is likely to have a protective effect in older persons. There is no theoretical reason to believe that the vaccine has a different safety profile in older and younger populations.

Does that mean something? Could one argue China is pushing WHO hard for political reasons?

I mean, many countries are desperate to get vaccines, but why have we bothered with tests with different age groups if "there's no theoretical reason" to conduct enough tests for certain people?

I'm not an expert in the field, so there's a chance the preliminary/supportive data does in fact prove the efficacy for older populations as well.

[1] https://www.who.int/news/item/07-05-2021-who-lists-additiona...